3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
7
CNS
2
Sarcoma
1
NET
1
Head & Neck
1
Conditions
Sarcoma
85
Osteosarcoma
37
Melanoma
23
Sarcoma, Ewing
22
Rhabdomyosarcoma
19
Ovarian Neoplasms
19
Neuroblastoma
19
Colorectal Neoplasms
18
Gastrointestinal Stromal Tumors
17
Glioblastoma
15
Breast Neoplasms
15
Bone Neoplasms
15
Sarcoma, Kaposi
14
Rhabdoid Tumor
14
Neoplasms
14
Wilms Tumor
13
Liposarcoma
13
Neoplasm Metastasis
12
Gliosarcoma
12
Glioma
12
Carcinoma, Non-Small-Cell Lung
12
Stomach Neoplasms
11
Medulloblastoma
11
Lymphoma, Non-Hodgkin
11
Hepatoblastoma
11
Neurofibrosarcoma
10
Thyroid Neoplasms
9
Recurrence
9
Pancreatic Neoplasms
9
Lymphoma
9
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adrenal Gland Neoplasms
×
Sarcoma
×
30 days
×
Clear all
NCT06607692
2026-06-04
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled